Colm Mac Eochagain (@ceochagain) 's Twitter Profile
Colm Mac Eochagain

@ceochagain

Consultant & Clinical Fellow
St James' Hospital Dublin

ID: 1233022692087009280

calendar_today27-02-2020 13:35:00

110 Tweet

228 Followers

628 Following

Peter B. Bach, MD (@peterbachmd) 's Twitter Profile Photo

Do we have the right priorities in oncology #ESMO2023 #ESMO23 - pictures taken a few minutes apart. Supportive care and Investigational therapy poster areas. Clinically these two are intertwined.

Do we have the right priorities in oncology #ESMO2023 #ESMO23 - pictures taken a few minutes apart. Supportive care and Investigational therapy poster areas. Clinically these two are intertwined.
Young SIOG (@youngsiog) 's Twitter Profile Photo

🎙️The next YSIOG forum will be held next week!🎙️ Date: Thursday November 2, 07:00 PM - 08:00 PM CET time Location: Zoom The Zoom link has been emailed to all YSIOG members. Looking forward to seeing you all next Thursday!

Enrique Soto (@enriquesoto8) 's Twitter Profile Photo

Hot off the press the new ASCO ESMO - Eur. Oncology global curriculum recommendations for Cancer Care in Older Adults #gerionc Every oncologist should have key competencies in geriatric care! We hope this gets integrated in programs globally @HansWildiers SIOG ascopubs.org/doi/full/10.12…

Hot off the press the new <a href="/ASCO/">ASCO</a> <a href="/myESMO/">ESMO - Eur. Oncology</a> global curriculum recommendations for Cancer Care in Older Adults #gerionc 
Every oncologist should have key competencies in geriatric care! We hope this gets integrated in programs globally @HansWildiers <a href="/SIOGorg/">SIOG</a> 
ascopubs.org/doi/full/10.12…
𝗔𝗺𝘆 𝗡𝗼𝗹𝗮𝗻 💛 (@amynolandublin) 's Twitter Profile Photo

🇪🇺🗣️If you’re a Healthcare Professional with experience in cancer service provision for patients with a physical or intellectual disability over 65 years-old - consider participating in this Irish Cancer Society funded EuCan Study. 💙 Contact: Shauna Walsh: [email protected]

Journal of Geriatric Oncology (@jgerionc) 's Twitter Profile Photo

A comparison of treatment allocation and survival between younger and older patients with HER2-overexpressing de novo metastatic breast cancer geriatriconcology.net/article/S1879-… Nienke de Glas William Dale, MD, PhD, FASCO @rochgerionc Cancer and Aging Research Group (CARG) #GeriOnc #GeriOnc #OlderAdults #OncoAlert #SIOG #YoungSIOG

A comparison of treatment allocation and survival between younger and older patients with HER2-overexpressing de novo metastatic breast cancer geriatriconcology.net/article/S1879-… <a href="/NienkedeGlas/">Nienke de Glas</a> <a href="/WilliamDale_MD/">William Dale, MD, PhD, FASCO</a> @rochgerionc <a href="/myCARG/">Cancer and Aging Research Group (CARG) #GeriOnc</a> #GeriOnc #OlderAdults #OncoAlert #SIOG #YoungSIOG
TILDA (@tilda_tcd) 's Twitter Profile Photo

We were delighted to be in St James's Hospital today for this fantastic meeting with #TSJCI . Rose Anne Kenny in full flight presenting an overview of TILDA: "The number of people with functional limitations will increase 5 fold by 2040"

We were delighted to be in <a href="/stjamesdublin/">St James's Hospital</a> today for this fantastic meeting with #TSJCI . <a href="/RoseAnnekenny1/">Rose Anne Kenny</a> in full flight presenting an overview of TILDA:
"The number of people with functional limitations will increase 5 fold by 2040"
Rose Anne Kenny (@roseannekenny1) 's Twitter Profile Photo

Looking forward to further collaboration with colleagues in cancer to grow opportunities for longitudinal data collection in #cancer survivors in collaboration with TILDA

The Oncologist (@oncjournal) 's Twitter Profile Photo

Dr Goggin and her co-investigators present a study revealing 57% cancer survivors have ⬇️ social networks. Only 37% of older patients had access to computer/internet 🖥️. ⬆️social isolation than general population. Caitríona Goggin #survonc #supponc doi.org/10.1093/oncolo…

Nicolò Battisti, MD (@nicolobattisti) 's Twitter Profile Photo

Delighted to see the The Royal Marsden NHS Foundation Trust Senior Adult Oncology Programme being awarded the prestigious 2024 HSJ Awards Patient Safety Congress & Awards Patient Safety Award in the category "Improving care for older people Initiative of the Year" yesterday evening in Manchester:

Joosje Baltussen (@jcbaltussen) 's Twitter Profile Photo

🚀 Already looking forward to the results of the IMPORTANT-trial, investigating lower starting doses of #CDK4/6 inhibitors and the role of the #geriatric assessment in older adults with mBC Congratulations to the authors for enrolling this study! tandfonline.com/doi/full/10.10…

Nicolò Battisti, MD (@nicolobattisti) 's Twitter Profile Photo

🚨 Come & join The Royal Marsden NHS Foundation Trust for a 2-year fellowship to conduct clinical research in cancer in older adults in a very supportive team with the opportunity to register for a research degree at The ICR Info available here: tinyurl.com/5fkr37b8 Closing date: 22/11/2024

🚨 Come &amp; join <a href="/royalmarsdenNHS/">The Royal Marsden NHS Foundation Trust</a> for a 2-year fellowship to conduct clinical research in cancer in older adults in a very supportive team with the opportunity to register for a research degree at <a href="/ICR_London/">The ICR</a>

Info available here: tinyurl.com/5fkr37b8

Closing date: 22/11/2024
Ana I. Velázquez Mañana, MD, MSc, FASCO (@anavmanana) 's Twitter Profile Photo

🚨 #ClinicalTrials Plenary at #AACR25 Ravi Uppaluri, MDPhD presents KEYNOTE-689 perioperative pembrolizumab + SOC improves EFS in locally advanced resectable HNSCC 🔹Subgroup analysis: no EFS benefit in stage IVA 🔹mPR 13.7% in CPS >=10 🔹Lower rates of path high-risk features

🚨 #ClinicalTrials Plenary at #AACR25 
<a href="/DrUppaluri/">Ravi Uppaluri, MDPhD</a> presents KEYNOTE-689 perioperative pembrolizumab + SOC improves EFS in locally advanced resectable HNSCC 
🔹Subgroup analysis: no EFS benefit in stage IVA 
🔹mPR 13.7% in CPS &gt;=10 
🔹Lower rates of path high-risk features